How to buy Ainos stock (AIMD)

Ainos is a medical devices business based in the US. Ainos shares (AIMD) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $0.55 – an increase of 0.93% over the previous week. Ainos employs 46 staff and has a trailing 12-month revenue of around $65,122.

Our top picks for where to buy Ainos stock

Buy Ainos stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Ainos stock price (NASDAQ: AIMD)

Use our graph to track the performance of AIMD stocks over time.

Ainos shares at a glance

• Key figures

Information last updated 2024-10-25.

Latest market close	$0.55
52-week range	$0.45 - $3.50
50-day moving average more info button	$0.55
200-day moving average more info button	$0.88
Wall St. target price	N/A
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-3.21

Is it a good time to buy Ainos stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Ainos price performance over time

Historical closes compared with the close of $0.545 from 2024-10-28

1 week (2024-10-22)	-3.02%
1 month (2024-09-30)	13.80%
3 months (2024-07-30)	-17.31%
6 months (2024-04-30)	-46.57%

1 year (2023-10-30)	-10.66%
2 years (2022-10-28)	-54.58%
3 years (2021-10-29)	9.72
5 years (2019-10-30)	30,177.78%

Ainos financials

Revenue TTM	$65,122
Gross profit TTM	$410,382
Return on assets TTM	-25.61%
Return on equity TTM	-60.31%
Profit margin	0%
Book value	$2.80
Market Capitalization more info button	$4.3 million

TTM: trailing 12 months

Ainos share dividends

We're not expecting Ainos to pay a dividend over the next 12 months.

Have Ainos's shares ever split?

Ainos's shares were split on a 1:5 basis on 13 December 2023 . So if you had owned 5 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Ainos shares – just the quantity. However, indirectly, the new 400% higher share price could have impacted the market appetite for Ainos shares which in turn could have impacted Ainos's share price.

Ainos share price volatility

Over the last 12 months, Ainos's shares have ranged in value from as little as $0.451 up to $3.495. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Ainos's is 1.412. This would suggest that Ainos's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Ainos overview

Ainos, Inc. , a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan. It also provides women's health, pneumonia, Ainos Pen, AI Nose, and other products. Ainos, Inc. was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc.

Frequently asked questions

null
What percentage of Ainos is owned by institutions?
Currently 1.109% of Ainos shares are held by institutions. How many people work for Ainos?
Latest data suggests 46 work at Ainos. When does the fiscal year end for Ainos?
Ainos's fiscal year ends in December. Where is Ainos based?
Ainos's address is: 8880 Rio San Diego Drive, San Diego, CA, United States, 92108 What is Ainos's ISIN number?
Ainos's international securities identification number is: US00902F1057